Variations in levels of blood clotting factors IX and X in a population of normal men: possible genetic polymorphisms.
作者信息
Lester R H, Elston R C, Graham J B
出版信息
Am J Hum Genet. 1972 Mar;24(2):168-80.
Abstract
摘要
相似文献
1
Variations in levels of blood clotting factors IX and X in a population of normal men: possible genetic polymorphisms.正常男性群体中凝血因子IX和X水平的变化：可能的基因多态性。
Am J Hum Genet. 1972 Mar;24(2):168-80.
2
Use of chromogenic peptide substrates in the determination of clotting factors II, VII, IX and X in normal plasma and in plasma of patients treated with oral anticoagulants.生色肽底物在正常血浆及口服抗凝剂治疗患者血浆中凝血因子II、VII、IX和X测定中的应用。
Haemostasis. 1982;12(3):241-55. doi: 10.1159/000214679.
3
4
Common intragenic and extragenic polymorphisms of blood coagulation factors VIII and IX are different in Chinese and Caucasian populations.凝血因子VIII和IX常见的基因内和基因外多态性在中国人和高加索人群中存在差异。
Clin Genet. 1990 Dec;38(6):434-40. doi: 10.1111/j.1399-0004.1990.tb03609.x.
5
Characterization of the clotting activities of structurally different forms of activated factor IX. Enzymatic properties of normal human factor IXa alpha, factor IXa beta, and activated factor IX Chapel Hill.结构不同形式的活化因子IX的凝血活性特征。正常人因子IXaα、因子IXaβ及活化因子IX查珀尔希尔的酶学特性。
J Clin Invest. 1985 Jan;75(1):4-10. doi: 10.1172/JCI111694.
6
Circadian rhythms of blood clotting time and coagulation factors II, VII, IX and X in rats.
Life Sci. 1989;45(25):2485-9. doi: 10.1016/0024-3205(89)90015-5.
7
Temporal variations in plasma vitamin K and lipid concentrations and clotting factor activity in humans.人体血浆维生素K、脂质浓度及凝血因子活性的时间变化
Am J Hematol. 2001 Nov;68(3):159-63. doi: 10.1002/ajh.1172.
8
9
Further studies on the "Dynia" clotting abnormality.
Thromb Diath Haemorrh. 1967 May 31;17(3-4):365-80.
10
The anticoagulant activity of 3-1-phenyl-propyl-4-hydroxycoumarin in patients on "long-term" therapy.
Arch Int Pharmacodyn Ther. 1972 Feb;195(2):240-6.
引用本文的文献
1
Monoclonal antibodies to coagulation factor IX define a high-frequency polymorphism by immunoassays.针对凝血因子IX的单克隆抗体通过免疫测定法确定了一种高频多态性。
Am J Hum Genet. 1985 Jul;37(4):668-79.
2
Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man.人体中S-羧甲基-L-半胱氨酸多峰分布硫氧化的遗传因素
Br J Clin Pharmacol. 1984 Oct;18(4):507-21. doi: 10.1111/j.1365-2125.1984.tb02498.x.
3
4
Major gene analysis of quantitative variation in blood clotting factor X levels.凝血因子X水平定量变异的主基因分析
Am J Hum Genet. 1979 Mar;31(2):199-213.
本文引用的文献
1
2
WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING.内源性凝血瀑布序列
Science. 1964 Sep 18;145(3638):1310-2. doi: 10.1126/science.145.3638.1310.
3
BRAIN SEROTONIN IN EXPERIMENTAL TYROSINOSIS.实验性酪氨酸血症中的脑血清素
Nature. 1964 May 2;202:495-6. doi: 10.1038/202495a0.
4
5
Stuart clotting defect. II. Genetic aspects of a new hemorrhagic state.斯图尔特凝血缺陷。二、一种新的出血状态的遗传学方面。
J Clin Invest. 1957 Mar;36(3):497-503. doi: 10.1172/JCI103447.
6
Genetic variants of hemophilia B: detection by means of a specific PTC inhibitor.B型血友病的基因变异：通过一种特定的PTC抑制剂进行检测。
J Clin Invest. 1968 Feb;47(2):360-5. doi: 10.1172/JCI105732.
7
Hemophilia A: polymorphism detectable by a factor 8 antibody.甲型血友病：可通过凝血因子 VIII 抗体检测到的多态性。
Science. 1969 Mar 7;163(3871):1071-2. doi: 10.1126/science.163.3871.1071.
8
Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor.经典血友病（因子Ⅷ缺乏症）和血管性血友病的免疫学分型，以及关于抗血友病因子和加速素（因子Ⅴ）联合缺乏症和一种获得性抗血友病因子循环抗凝剂的观察
J Clin Invest. 1971 Jan;50(1):244-54. doi: 10.1172/JCI106480.
9
Genetics of human blood coagulation.人类血液凝固的遗传学
J Med Genet. 1965 Dec;2(4):254-303. doi: 10.1136/jmg.2.4.254.
10
Factor 8 detection by hemagglutination inhibition: hemophilia A and von Willebrand's disease.通过血凝抑制检测因子VIII：甲型血友病和血管性血友病。
Science. 1971 Jan 15;171(3967):196-7. doi: 10.1126/science.171.3967.196.
Zotero 插件